Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.48 USD | -0.40% | -1.77% | +36.50% |
05-31 | Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target | MT |
05-10 | Tranche Update on LeMaitre Vascular, Inc.'s Equity Buyback Plan announced on February 27, 2024. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.50% | 1.74B | |
+9.48% | 222B | |
+13.72% | 195B | |
+23.79% | 148B | |
+33.39% | 113B | |
+4.75% | 66.45B | |
+15.59% | 53.11B | |
+3.16% | 50.03B | |
-4.35% | 38.8B | |
-1.27% | 34.85B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- LeMaitre Vascular : Roth Capital Adjusts LeMaitre Vascular PT to $36 From $32, Maintains Neutral Rating